CABR (CABR)
Caring Brands, Inc. operates in the wellness consumer products sector, offering over-the-counter and cosmetic solutions. Incorporated in 2020, the company focuses on addressing various health and wellness needs through specialized product lines.
Company Overview
Caring Brands, Inc. (CABR) offers targeted wellness solutions in the over-the-counter and cosmetic product market, focusing on specialized treatments for hair loss, skin conditions, and sexual wellness, positioning itself for growth in niche consumer health segments.
Investment Thesis
Investing in Caring Brands, Inc. (CABR) presents a speculative opportunity within the wellness consumer products market. The company's focus on niche segments like hair loss, skin conditions, and women's sexual wellness offers potential for targeted growth. With a market capitalization of $0.01 billion, CABR is a micro-cap stock with significant upside potential if it can successfully execute its growth strategy. Key value drivers include expanding distribution channels, increasing brand awareness, and launching new innovative products. Upcoming catalysts include potential partnerships with larger retailers and positive clinical trial results for new product formulations. The investment thesis hinges on CABR's ability to capture market share in its targeted segments and achieve significant revenue growth over the next 3-5 years.
Key Highlights
- Caring Brands, Inc. was incorporated in 2020, indicating a relatively young company with potential for growth.
- The company focuses on over-the-counter and cosmetic consumer products, tapping into the growing wellness market.
- CABR offers a range of specialized products, including hair loss treatments and solutions for skin conditions like eczema and psoriasis.
- The company's market capitalization is $0.01 billion, classifying it as a micro-cap stock.
- CABR's headquarters are located in Jupiter, Florida.
Competitors
Strengths
- Specialized product portfolio.
- Focus on niche markets.
- Potential for strong brand reputation.
- Innovative product development.
Weaknesses
- Limited brand awareness.
- Small market capitalization.
- Dependence on specific product lines.
- Limited financial resources.
Catalysts
- Upcoming: Potential partnerships with major retailers to expand distribution.
- Upcoming: Positive clinical trial results for new product formulations.
- Ongoing: Expansion of online sales channels and direct-to-consumer marketing efforts.
- Ongoing: Increasing brand awareness through social media and influencer marketing.
- Ongoing: Development and launch of new innovative products.
Risks
- Potential: Competition from larger, more established companies with greater resources.
- Potential: Changing consumer preferences and trends in the wellness market.
- Potential: Regulatory changes affecting the sale and marketing of over-the-counter products.
- Ongoing: Dependence on specific product lines and limited diversification.
- Ongoing: Economic downturn affecting consumer spending on wellness products.
Growth Opportunities
- Expansion of Distribution Channels: Caring Brands can expand its distribution channels by partnering with major retailers, pharmacies, and online marketplaces. This would increase product availability and reach a wider customer base. The global e-commerce market is projected to reach $6.2 trillion in 2024, providing a significant opportunity for online sales growth. Timeline: Within the next 1-2 years, CABR should focus on securing partnerships with key retailers and expanding its online presence.
- New Product Development: Investing in research and development to create new and innovative products can drive growth. Focusing on emerging trends in the wellness market, such as personalized skincare and natural ingredients, can attract new customers. The global cosmetic market is expected to reach $463.5 billion by 2027. Timeline: Ongoing, with new product launches planned every 12-18 months.
- Strategic Partnerships: Collaborating with healthcare providers, wellness influencers, and other strategic partners can enhance brand credibility and reach new customers. Partnering with dermatologists and other medical professionals can provide valuable endorsements and increase consumer trust. Timeline: Within the next year, CABR should focus on establishing partnerships with key influencers and healthcare providers.
- International Expansion: Expanding into international markets can significantly increase revenue potential. Focusing on regions with high demand for wellness products, such as Asia and Europe, can drive growth. The global wellness market is estimated at $4.7 trillion. Timeline: Within the next 2-3 years, CABR should explore opportunities for international expansion.
- Direct-to-Consumer (DTC) Sales: Developing a strong DTC channel can improve margins and build direct relationships with customers. Investing in e-commerce platforms and digital marketing can drive online sales. The DTC market is growing rapidly, with consumers increasingly preferring to purchase products directly from brands. Timeline: Ongoing, with continuous improvement of the DTC channel.
Opportunities
- Expansion into new markets.
- Development of new products.
- Strategic partnerships.
- Increased online sales.
Threats
- Competition from larger companies.
- Changing consumer preferences.
- Regulatory changes.
- Economic downturn.
Competitive Advantages
- Specialized product portfolio targeting niche markets.
- Focus on specific health and wellness needs.
- Potential for strong brand reputation in targeted segments.
- Proprietary formulations and technologies.
About
Caring Brands, Inc. was established in 2020 and is headquartered in Jupiter, Florida. The company operates within the wellness consumer products industry, focusing on the development, marketing, and distribution of over-the-counter (OTC) and cosmetic consumer products. CABR's product portfolio includes solutions for hair loss, eczema and psoriasis treatments, vitiligo solutions, a jellyfish sting protective suncare line, and women's sexual wellness products. These products are designed to address specific health and wellness needs of consumers. Caring Brands aims to cater to underserved segments within the broader health and wellness market by offering specialized and targeted solutions. The company's strategy involves identifying unmet consumer needs and developing products that provide effective and accessible solutions. As a relatively young company, Caring Brands is focused on establishing its brand presence and expanding its market reach through strategic partnerships and distribution channels. The company's focus on niche markets allows it to differentiate itself from larger players in the consumer health industry. Caring Brands' success will depend on its ability to innovate, effectively market its products, and build a strong reputation for quality and efficacy.
What They Do
- Develop and market over-the-counter (OTC) consumer products.
- Offer cosmetic consumer products.
- Provide hair loss treatments.
- Offer solutions for eczema and psoriasis.
- Develop vitiligo solutions.
- Create a jellyfish sting protective suncare line.
- Offer women's sexual wellness products.
Business Model
- Develop and manufacture wellness consumer products.
- Market and distribute products through various channels.
- Generate revenue through product sales.
- Focus on niche markets within the wellness industry.
Industry Context
Caring Brands operates in the competitive wellness consumer products industry, which is characterized by increasing demand for over-the-counter and cosmetic solutions. The market is driven by growing consumer awareness of health and wellness, as well as an aging population seeking solutions for age-related conditions. The industry includes large, established players as well as smaller, niche-focused companies like Caring Brands. Competitors include companies such as ATGGF (Ascend Wellness Holdings, Inc.), CLTEF (Celestial Biolabs Inc.), DBCCF (Deep Blue Company, Inc.), ETST (Earth Science Tech, Inc.), and MDXHF (Medixium Corp). Caring Brands differentiates itself by focusing on specialized product lines and targeted marketing strategies.
Key Customers
- Individuals seeking hair loss treatments.
- People with eczema and psoriasis.
- Individuals looking for vitiligo solutions.
- Consumers needing sun protection from jellyfish stings.
- Women seeking sexual wellness products.
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2024 | $465 | $-333,623 | $0.00 |
| Q3 2025 | $740 | -$1M | $-0.08 |
Source: Company filings
Chart & Info
Price Chart
CABR (CABR) stock price: $0.91 (+0.07, +7.93%)
Latest News
-
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session
benzinga · Feb 20, 2026
-
Caring Brands Secures Two U.S. Patents Enhancing Enzymatic Activity In Hair Follicles, Supporting Hair Enzyme Booster IP Portfolio
benzinga · Feb 3, 2026
-
Caring Brands Secures Two New U.S. Patents Strengthening Hair Enzyme Booster Technology
Yahoo! Finance: CABR News · Feb 3, 2026
-
Caring Brands Secures Two New U.S. Patents Strengthening Hair Enzyme Booster Technology
GlobeNewswire · Feb 3, 2026
Technical Analysis
Rationale
AI-generated technical analysis for CABR including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss CABR (CABR) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for CABR.
Make a Prediction
Set your price target for CABR (CABR), choose a timeframe, and track your prediction accuracy.
Current price: $0.91
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CABR.
Price Targets
Wall Street price target analysis for CABR.
Insider Flow (30d)
MoonshotScore
Score Factors
-
Revenue Growth 5/100
Revenue growth data is currently unavailable for this company.
-
Gross Margin 3/100
Gross margin of -6.9% is below average, suggesting thin margins and potential pricing pressure.
-
Operating Leverage 4/100
Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.
-
Cash Runway 5/100
Cash position data is currently unavailable for this company.
-
R&D Intensity 5/100
R&D spending data is currently unavailable for this company.
-
Insider Activity 6/100
No significant insider buying or selling recently, which is neutral for the stock outlook.
-
Short Interest 5/100
Float and volume data unavailable for liquidity analysis.
-
Price Momentum 0/100
No bullish technical signals detected. The stock lacks upward price momentum currently.
-
News Sentiment 5/100
No sentiment data available
What does this score mean?
The MoonshotScore rates CABR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session
Caring Brands Secures Two U.S. Patents Enhancing Enzymatic Activity In Hair Follicles, Supporting Hair Enzyme Booster IP Portfolio
Caring Brands Secures Two New U.S. Patents Strengthening Hair Enzyme Booster Technology
Caring Brands Secures Two New U.S. Patents Strengthening Hair Enzyme Booster Technology
Frequently Asked Questions
What does Caring Brands, Inc. do?
Caring Brands, Inc. is a wellness consumer products company that develops, markets, and distributes over-the-counter (OTC) and cosmetic products. The company focuses on addressing specific health and wellness needs through specialized product lines, including hair loss treatments, solutions for skin conditions like eczema and psoriasis, vitiligo solutions, a jellyfish sting protective suncare line, and women's sexual wellness products. CABR targets niche markets within the broader health and wellness industry, aiming to provide effective and accessible solutions to consumers.
Is CABR stock a good buy?
CABR stock represents a high-risk, high-reward investment opportunity. With a market capitalization of $0.01 billion, it is a micro-cap stock with significant growth potential if the company can successfully execute its strategy. Factors to consider include the company's ability to expand distribution channels, develop new products, and increase brand awareness. Investors should carefully evaluate their risk tolerance and conduct thorough due diligence before investing. The company's focus on niche markets and potential for strategic partnerships could drive future growth.
What are the main risks for CABR?
The main risks for CABR include competition from larger, more established companies with greater resources, changing consumer preferences and trends in the wellness market, and regulatory changes affecting the sale and marketing of over-the-counter products. Additionally, the company's dependence on specific product lines and limited diversification pose risks. An economic downturn could also affect consumer spending on wellness products, impacting CABR's revenue. Investors should be aware of these risks and consider their potential impact on the company's performance.
Is CABR a good stock to buy?
Whether CABR is a good investment depends on your financial goals, risk tolerance, and investment horizon. Key factors to evaluate include the company's revenue growth trajectory, profit margins, debt-to-equity ratio, competitive moat, and valuation multiples (P/E, P/S, EV/EBITDA) relative to industry peers. Our AI-generated Investment Thesis and SWOT analysis on this page provide a data-driven starting point. Always do your own research and consider consulting a financial advisor before making investment decisions.
What is the CABR MoonshotScore?
The MoonshotScore for CABR is an AI-powered rating from 0 to 100 that evaluates a stock across four dimensions: growth potential (revenue and earnings trajectory), financial health (balance sheet strength, cash flow), market momentum (price trends, volume patterns, institutional flows), and risk factors (volatility, debt levels, sector headwinds). Scores above 70 indicate strong potential, 50-70 moderate, and below 50 suggests caution. The score is recalculated daily using the latest financial data and market signals.
How often is CABR data updated?
CABR stock prices are updated in real-time during U.S. market hours (9:30 AM - 4:00 PM ET, Monday through Friday). After-hours and pre-market prices are also tracked. Company fundamentals (earnings, revenue, balance sheet) are refreshed when new quarterly or annual reports are filed. Analyst ratings, price targets, and AI-generated insights are updated daily. Breaking news related to CABR is aggregated continuously from premium financial news sources throughout the day.
What are the growth catalysts for CABR?
Growth catalysts for CABR (CABR) can include several categories: product catalysts (new launches, FDA approvals, patent grants), financial catalysts (earnings beats, margin expansion, share buybacks), strategic catalysts (acquisitions, partnerships, market expansion into new regions), and macro catalysts (favorable regulation, industry tailwinds, secular growth trends). Our AI analyzes CABR's specific catalysts using earnings transcripts, SEC filings, and news sentiment to identify the most impactful near-term and long-term drivers.
Who are CABR's main competitors?
CABR (CABR) competes with companies in its industry that target similar customers, markets, or product categories. Competitor analysis involves comparing key metrics: market share, revenue growth rates, profit margins, R&D spending, and valuation multiples. Understanding competitive positioning helps investors assess whether CABR has a sustainable competitive advantage (moat) through brand strength, network effects, cost leadership, or switching costs. Our Competitors section provides a side-by-side comparison with relevant peers.
What do analysts say about CABR?
Wall Street analyst coverage for CABR includes consensus ratings (buy, hold, or sell), 12-month price targets, and earnings estimates. Analyst opinions are aggregated from major investment banks and research firms. Key metrics to watch include the consensus price target (average, high, and low estimates), the number of analysts covering the stock, any recent rating changes (upgrades or downgrades), and how actual earnings compare to analyst estimates (beat or miss history). Our platform aggregates these from multiple data providers for a comprehensive view.
What is CABR's market cap?
Market capitalization (market cap) for CABR is calculated by multiplying the current share price by the total number of outstanding shares. It represents the market's total valuation of the company. Stocks are typically categorized as mega-cap ($200B+), large-cap ($10B-$200B), mid-cap ($2B-$10B), small-cap ($300M-$2B), or micro-cap (under $300M). Market cap influences index inclusion, institutional ownership eligibility, and risk profile. Our Key Statistics section shows CABR's current market cap alongside enterprise value and other valuation metrics.
How has CABR stock performed recently?
CABR's recent stock performance can be evaluated across multiple timeframes: daily price changes, week-over-week momentum, monthly trends, and year-to-date returns. Important performance indicators include the stock's 52-week high and low, moving averages (50-day and 200-day SMA), relative strength index (RSI), and volume trends. Comparing CABR's performance against its sector index and the S&P 500 provides context on whether it is outperforming or underperforming the broader market.
What are the risks of investing in CABR?
Key risk categories for CABR include: market risk (overall market downturns affecting stock prices), company-specific risk (management changes, product failures, competitive threats), financial risk (high debt levels, cash burn, dilution from stock issuance), regulatory risk (government policy changes, lawsuits, compliance issues), and macroeconomic risk (interest rate changes, inflation, currency fluctuations). Beta measures CABR's volatility relative to the market - a beta above 1.0 means higher volatility than the S&P 500. Our AI-generated risk assessment identifies the most relevant risk factors for this specific stock.
Are insiders buying or selling CABR?
Insider trading activity for CABR tracks purchases and sales by company executives, directors, and major shareholders (10%+ owners) as reported in SEC Form 4 filings. Insider buying is generally considered a bullish signal because insiders have the deepest knowledge of company operations, while selling may have various motivations (diversification, tax planning, pre-planned 10b5-1 trading plans). Key metrics include the buy-to-sell ratio, total dollar value of insider transactions, and whether multiple insiders are trading in the same direction. Our Insider Flow tab shows recent transactions with dates and dollar amounts.
Is CABR a good stock for beginners?
CABR (CABR) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.
How risky is CABR for first-time investors?
Every stock carries risk, including CABR (CABR). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like CABR.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.
- Limited financial data available.
- Micro-cap stock with high volatility.